Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 605
Recruiting: 316
Ph III recruiting: 30
Growth YoY: +37.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (571)

clinicaltrialsPublishedShowing 51–64 of 64 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02065466	Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases	withdrawn	Phase 1 / Phase 2	0	University of ArizonaOTHER	1	Apr 21, 2016	clinicaltrials
NCT02452281	Pilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced Melanoma	withdrawn	Phase 1 / Phase 2	0	Rabih SaidOTHER	1	Jan 25, 2016	clinicaltrials